Wyeth Paying $491M To End Criminal, Civil Rapamune Cases
By Megan Stride · July 30, 2013, 5:44 PM EDT
Wyeth Pharmaceuticals Inc. has agreed to shell out $491 million to end a criminal action as well as civil False Claims Act cases alleging it illegally marketed its immunosuppressive drug Rapamune...
To view the full article, register now.